High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 91, Issue 2, 2009, Pages 845-854

  Alikhani, Azadeh ^a,b   Korchagina, Elena Y ^c   Chinarev, Alexander A ^c   Bovin, Nicolai V ^c   Federspiel, William J ^a,b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

ABO incompatible transplantation; Glycoconjugates; Hyperacute rejection; Immunoadsorption; Kinetics; Surface plasmon resonance

Indexed keywords

ANTIBODY BINDING; ANTIBODY REMOVAL; BINDING INTERACTION; BLOOD GROUP; CARBOHYDRATE CONTENT; GLYCOCONJUGATES; GLYCOPOLYMERS; HIGH MOLECULAR WEIGHT; HOLLOW FIBER; HYPERACUTE REJECTION; IMMUNOADSORPTION; LOW MOLECULAR WEIGHT; POLYACRY LAMIDE; SENSOR CHIPS; SURFACE AREA;

ANTIGENS; BINDING ENERGY; BLOOD; BLOOD SUBSTITUTES; CARBOHYDRATES; COENZYMES; FLUORINE CONTAINING POLYMERS; MOLECULAR WEIGHT; PLASMONS; SURFACE PLASMON RESONANCE;

ANTIBODIES;

BIOTIN; BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; GLYCOCONJUGATE; POLYACRYLAMIDE; STREPTAVIDIN; TRISACCHARIDE; TRISACCHARIDE POLYACRYLAMIDE GLYCOCONJUGATE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BLOOD GROUP A; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; FILTER; HOLLOW FIBER; HUMAN; IMMOBILIZATION; IMMUNOADSORPTION; MOLECULAR WEIGHT; SENSOR; SURFACE PLASMON RESONANCE;

ACRYLIC RESINS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; BIOSENSING TECHNIQUES; BIOTIN; BLOOD GROUP ANTIGENS; IMMUNOCHEMISTRY; IMMUNOGLOBULIN M; INDICATORS AND REAGENTS; KINETICS; MOLECULAR WEIGHT; TRISACCHARIDES;

EID: 71649113409     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31466     Document Type: Article

References (46)

1. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med 2001;11:325-342.
2. Watkins WM. The ABO blood group system: Historical background. Transfus Med 2001;11:243-265. (Pubitemid 32771920)
3. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Immunology, 5th ed. New York: W.H. Freeman and Company; 2003.
4. Tydén G. The European Experience. Transplantation 2007;84 (12 Suppl):S2-S3.
5. Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, Fuchinoue S, Oshima T, Yagisawa T, Nakazawa H, Goya N, Koga S, Kawaguchi H, Ito K, Toma H, Agishi T, Ota K. Long-term results of ABO-incompatible living kidney transplantation: A single-center experience. Transplantation 1998;65:224-228. (Pubitemid 28101328)
6. Boberg KM, Foss A, Midtvedt K, Schrumpf E. ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody. Clin Transplant 2006;20:265-268.
7. Donauer J, Wilpert J, Geyer M, Schwertfeger E, Kirste G, Drognitz O, Walz G, Pisarski P. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A single center experience. Xenotransplantation 2006;13:108-110.
8. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl 2003;9:22-30.
9. Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz ME, Emre S, Thung SN, Miller CM. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 1995;59:986-990.
10. Norden G, Briggs D, Cockwell P, Lipkin G, Mjornstedt L, Molne J, Ready A, Rydberg L, Samuelsson O, Svalander CT, Breimer ME. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006;13:148-153.
11. Skogsberg U, Breimer ME, Friman S, Mjornstedt L, Molne J, Olausson M, Rydberg L, Svalander CT, Backman L. Adult ABO-incompatible liver transplantation, using A and B donors. Xenotransplantation 2006;13:154-159. (Pubitemid 44693642)
12. Troisi R, Noens L, Montalti R, Ricciardi S, Philippe J, Praet M, Conoscitore P, Centra M, de Hemptinne B. ABOmismatch adult living donor liver transplantation using antigen- specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl 2006;12:1412-1417. (Pubitemid 44405131)
13. Alexandre GP, De Bruyere M, Squifflet JP, Moriau M, Latinne D, Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med 1985;28:231-234. (Pubitemid 15095584)
14. Bannett AD, McAlack RF, Raja R, Baquero A, Morris M. Experiences with known ABO-mismatched renal transplants. Transplant Proc 1987;19:4543-4546. (Pubitemid 18049657)
15. Tanabe K, Takahashi K, Sonda K, Agishi T, Kawaguchi H, Ishikawa N, Kimata N, Oshima S, Goya N, Nakazawa H, Fuchinoue S, Kawal T, et al. ABO-incompatible living kidney donor transplantation: Results and immunological aspects. Transplant Proc 1995;27: 1020-1023.
16. Galili U. Immune response, accommodation, and tolerance to transplantation carbohydrate antigens. Transplantation 2004; 78:1093-1098. (Pubitemid 39426422)
17. Bouget J, Chevret S, Chastang C, Raphael JC. Plasma exchange morbidity in Guillain-Barre syndrome: Results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit Care Med 1993;21: 651-658. (Pubitemid 23139541)
18. Madore F. Plasmapheresis. Technical aspects and indications. Crit Care Clin 2002;18:375-392.
19. Rieben R, Korchagina EY, von Allmen E, Hovinga JK, Lammle B, Jungi TW, Bovin NV, Nydegger UE. In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation 1995;60:425-430.
20. Gautam S, Korchagina EY, Bovin NV, Federspiel WJ. Monoclonal anti-A antibody removal by synthetic A antigen immobilized on specific antibody filters. Biotechnol Bioeng 2008;99:876-883. (Pubitemid 351316630)
21. Hout MS, LeJeune KE, Schaack TM, Bristow DK, Federspiel WJ. Specific removal of anti-A and anti-B antibodies by using modified dialysis filters. ASAIO J 2000;46:702-706.
22. Rieben R, Korchagina EY, Bovin NV, Daha MR. Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates. Transfus Clin Biol 1997;4:47-54. (Pubitemid 27225751)
23. Rydberg L, Bengtsson A, Samuelsson O, Nilsson K, Breimer ME. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2005;17:666-672.
24. Solovan JC, Oh HI, Alikhani A, Gautam S, Vlasova K, Korchagina EY, Bovin NV, Federspiel WJ. Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM. Transpl Immunol 2006;16:245-249. (Pubitemid 44809911)
25. Soltys PJ, Etzel MR. Equilibrium adsorption of LDL and gold immunoconjugates to affinity membranes containing PEG spacers. Biomaterials 2000;21:37-48.
26. Ross EA, Branham ML, Tebbett IR. Optimization of ligand presentation for immunoadsorption using star-configured polyethylene glycols. J Biomed Mater Res 2000;51:29-36.
27. Bensinger W, Petersen FB, Banaji M, Buckner CD, Clift R, Slichter SJ, Storb R, Thomas ED. Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission. Bone Marrow Transplant 1989;4:409-414.
28. Walker RH. American Association of Blood Banks. Technical Manual, 11th ed. Bethesda: American Association of Blood Banks; 1993.
29. Korchagina EY, Bovin NV. Synthesis of spacered trisaccharides with blood group A and B specificities and fragments and structural analogues of them. Sov J Bioorg Chem 1992;18:153-165.
30. Bovin NV, Korchagina EY, Zemlyanukhina TV, Byramova NE, Galanina OE, Zemlyakov AE, Ivanov AE, Zubov VP, Mochalova LV. Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides. Glycoconj J 1993; 10:142-151. (Pubitemid 23233227)
31. Shilova NV, Galanina OE, Pochechueva TV, Chinarev AA, Kadykov VA, Tuzikov AB, Bovin NV. High molecular weight neoglycoconjugates for solid phase assays. Glycoconj J 2005;22:43-51.
32. Yarmush ML. Patankar DB. Yarmush DM. An analysis of transport resistances in the operation of BIAcore(TM); implications for kinetic studies of biospecific interactions. Mol Immunol 1996;33:1203-1214.
33. Fagerstam LG, O'Shannessy DJ. Surface plasmon resonance detection in affinity technologies. In: Kline T, editor. Handbook of Affinity Chromatography. New York: Marcel Dekker, Inc.; 1993.
34. Morton TA, Myszka DG, Chaiken IM. Interpreting complex binding kinetics from optical biosensors: A comparison of analysis by linearization, the integrated rate equation, and numerical integration. Anal Biochem 1995;227:176-185.
35. Brandt S, Goffe RA, Kessler SB, O'Connor JL, Zale SE. Membrane based affinity technology for commercial scale purifications. Biotechnology 1988;6:779-782. (Pubitemid 18253596)
36. Thomas R, Patenaude SI, MacKenzie CR, To R, Hirama T, Young NM, Evans SV. Structure of an anti-blood group A Fv and improvement of its binding affinity without loss of specificity. J Biol Chem 2002;277:2059-2064. (Pubitemid 34968788)
37. Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM, Marks C, Marks JD. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol 1996;263:551-567. (Pubitemid 26382075)
38. Yang WP, Green K, Pinz-Sweeney S, Briones AT, Burton DR, Barbas CF III. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 1995;254:392-403. (Pubitemid 26001779)
39. Karlsson R, Jendeberg L, Nilsson B, Nilsson J, Nygren PA. Direct and competitive kinetic analysis of the interaction between human IgG1 and a one domain analogue of protein A. J Immunol Methods 1995;183:43-49.
40. Harrison BA, MacKenzie R, Hirama T, Lee KK, Altman E. A kinetics approach to the characterization of an IgM specific for the glycolipid asialo-GM1. J Immunol Methods 1998; 212:29-39. (Pubitemid 28288184)
41. Drake AW, Myszka DG, Klakamp SL. Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibriumbased methods. Anal Biochem 2004;328:35-43.
42. Kortt AA, Gruen LC, Oddie GW. Influence of mass transfer and surface ligand heterogeneity on quantitative BIAcore binding data. Analysis of the interaction of NC10 Fab with an anti-idiotype Fab'. J Mol Recognit 1997;10:148-158.
43. Glaser RW. Antigen-antibody binding and mass transport by convection and diffusion to a surface: A two-dimensional computer model of binding and dissociation kinetics. Anal Biochem 1993;213:152-161. (Pubitemid 23250630)
44. Christensen LLH. Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation. Anal Biochem 1997;249:153-164. (Pubitemid 27291095)
45. Hout MS, Federspiel WJ. Mathematical and experimental analyses of antibody transport in hollow-fiber-based specific antibody filters. Biotechnol Prog 2003;19:1553-1561.
46. Bovin NV. Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconj J 1998;15:431-446.